Who owns TSCAN THERAPEUTICS INC?
- Ticker: TCRX
- CUSIP Number: 89854m101
Tip: Access positions for across all investors
Analyze quarterly positions in Tscan Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tscan Therapeutics stock
Who bought or sold TSCAN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lynx1 Capital Management | 8.0M | $8.1M | 0% | Mar 2026 |
|
| BVF | 5.6M | $5.6M | 6% | Mar 2026 |
|
| Baker Bros. Advisors | 2.8M | $2.8M | 0% | Mar 2026 |
|
| Vanguard Group | 2.5M | $2.5M | 7% | Dec 2025 |
|
| Vanguard Capital Management | 2.2M | $2.2M | 100% | Mar 2026 |
|
| BlackRock | 1.8M | $1.9M | 0% | Mar 2026 |
|
| Millennium Management | 1.5M | $1.5M | 262% | Mar 2026 |
|
| Deer Management | 1.2M | $1.3M | 0% | Mar 2026 |
|
| Two Sigma Investments | 1.2M | $1.2M | 86% | Mar 2026 |
|
| Renaissance Technologies | 1.1M | $1.1M | 37% | Dec 2025 |
|
| Standard Life Aberdeen | 918k | $927k | -49% | Mar 2026 |
|
| Jacobs Levy Equity Management | 808k | $816k | 330% | Mar 2026 |
|
| DC Funds | 630k | $630M | 0% | Mar 2026 |
|
| Geode Capital Management | 617k | $623k | 10% | Mar 2026 |
|
| GSA Capital Partners | 379k | $383k | 68% | Mar 2026 |
|
| Marshall Wace | 339k | $339k | 628% | Dec 2025 |
|
| D. E. Shaw & Co | 320k | $323k | 360% | Mar 2026 |
|
| Citadel Advisors | 318k | $322k | 95% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 306k | $309k | 100% | Mar 2026 |
|
| XTX Topco | 219k | $219k | 1142% | Dec 2025 |
|
| Susquehanna International | 216k | $216k | 171% | Dec 2025 |
|
| State Street Corporation | 207k | $207k | 5% | Dec 2025 |
|
| Acadian Asset Management | 202k | $201k | 584% | Mar 2026 |
|
| Morgan Stanley | 174k | $175k | -23% | Mar 2026 |
|
| Jane Street | 144k | $146k | -63% | Mar 2026 |
|
| Brown Brothers Harriman & Co. | 143k | $145k | 0% | Mar 2026 |
|
| Bridgeway Capital Management | 115k | $115k | -18% | Dec 2025 |
|
| Northern Trust | 98k | $98k | 0% | Dec 2025 |
|
| Letko, Brosseau & Associates | 96k | $97k | 0% | Mar 2026 |
|
| NewEdge Wealth | 92k | $92k | 0% | Mar 2026 |
|
| Stifel Financial | 69k | $70k | -4% | Mar 2026 |
|
| Dimensional Fund Advisors | 65k | $66k | -12% | Mar 2026 |
|
| Kestra Advisory Services | 63k | $63k | 100% | Mar 2026 |
|
| Bank of America Corporation | 58k | $58k | 100% | Mar 2026 |
|
| Ameriprise Financial | 53k | $53k | 100% | Mar 2026 |
|
| Nine Masts Capital | 42k | $42k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 37k | $38k | -57% | Mar 2026 |
|
| Dean Capital Investments Management | 36k | $36k | 0% | Mar 2026 |
|
| UBS Group | 33k | $33k | -41% | Mar 2026 |
|
| Prudential Financial | 30k | $30k | 22% | Mar 2026 |
|
| PanAgora Asset Management | 29k | $29k | 14% | Mar 2026 |
|
| Hsbc Holdings | 25k | $24k | 0% | Mar 2026 |
|
| Barclays | 23k | $23k | 22% | Dec 2025 |
|
| LPL Financial | 23k | $23k | 0% | Mar 2026 |
|
| JustInvest | 21k | $22k | 46% | Mar 2026 |
|
| Neuberger Berman Group | 18k | $18k | 0% | Dec 2025 |
|
| Vanguard Global Advisers | 16k | $16k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 12k | $12k | 0% | Dec 2025 |
|
| Aries Wealth Management | 10k | $10k | 0% | Dec 2025 |
|
| Tower Research Capital | 6.8k | $6.8k | -39% | Dec 2025 |
|
| Federated Investors | 4.3k | $4.3k | -14% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 713.00 | $719.987400 | -97% | Mar 2026 |
|
| FMR | 500.00 | $500.000000 | -95% | Dec 2025 |
|
| SBI Securities | 392.00 | $395.998400 | 0% | Mar 2026 |
|
| Strategic Wealth Partners | 311.00 | $313.985600 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 73.00 | $0 | -91% | Mar 2026 |
|
| Caitong International Asset Management | 2.00 | $2.000000 | 100% | Mar 2026 |
|
| Citigroup | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Tscan Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 354k | $354k |
| Jpmorgan Chase & Co | Sep 2025 | 238k | $433k |
| Militia Capital Partners | Sep 2025 | 102k | $186k |
| Virtu Financial | Sep 2025 | 61k | $110k |
| Tang Capital Management | Dec 2025 | 46k | $46k |
| Qube Research & Technologies | Sep 2025 | 28k | $50k |
| Hrt Financial | Dec 2025 | 27k | $26k |
| R Squared | Dec 2025 | 16k | $16k |
| Two Sigma Securities | Dec 2025 | 16k | $16k |
| Point72 Asset Management | Dec 2025 | 15k | $15k |
| Waldron | Dec 2025 | 10k | $10k |
| Mizuho Securities Usa | Dec 2025 | 10k | $10k |
| Rialto Wealth Management | Sep 2025 | 381.00 | $693.991500 |
| Rockefeller Capital Management | Dec 2025 | 200.00 | $200.000000 |
| Northwestern Mutual Wealth Management Company | Dec 2025 | 8.00 | $8.000000 |
| CWM | Sep 2025 | 8.00 | $0 |